Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3738182 | 0.89 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL1931611 | 0.87 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL5838258 | 0.85 | TSHR (0.39) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL10430815 | 0.81 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL18918481 | 0.81 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL3738205 | 0.81 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL3746493 | 0.81 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL3738193 | 0.81 | TSHR (0.37) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL11220689 | 0.81 | TSHR (0.39) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL3832655 | 0.80 | TSHR (0.36) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5023159-A | Encapsulated electrophotographic toner compositions | XEROX CORPORATION (US) | 1991-06-11 | — | — | US | claimed |
| US-12641921-B2 | Method for forming structure comprising quantum dots in surface control region, surface control substrate having structure formed to comprise quantum dots, and photoelectric element using same | KOREA ADVANCED NANO FAB CENTER (KR) | 2026-05-26 | — | — | US | disclosed |
| CN-119969418-A | Water-based bactericidal emulsion and preparation method thereof | 福建华夏蓝新材料科技有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-115175952-B | Aqueous resin composition, aqueous paint and coated article | DIC株式会社 | 2023-08-29 | — | — | CN | disclosed |
| US-20230178682-A1 | METHOD FOR FORMING STRUCTURE COMPRISING QUANTUM DOTS IN SURFACE CONTROL REGION, SURFACE CONTROL SUBSTRATE HAVING STRUCTURE FORMED TO COMPRISE QUANTUM DOTS, AND PHOTOELECTRIC ELEMENT USING SAME | KOREA ADVANCED NANO FAB CENTER (KR) | 2023-06-08 | — | — | US | disclosed |
| WO-2022145615-A1 | METHOD FOR FORMING STRUCTURE COMPRISING QUANTUM DOTS IN SURFACE CONTROL REGION, SURFACE CONTROL SUBSTRATE HAVING STRUCTURE FORMED TO COMPRISE QUANTUM DOTS, AND PHOTOELECTRIC ELEMENT USING SAME | (재)한국나노기술원 | 2022-07-07 | — | — | WO | disclosed |
| CN-110003475-B | Ultraviolet-curable carboxyl silicone oil and preparation method and application thereof | 广东工业大学 | 2022-01-25 | — | — | CN | disclosed |
| US-8551353-B2 | Hierarchical structure and manufacturing method thereof | KOREA INSTITUTE OF MACHINERY & MATERIALS (KR) | 2013-10-08 | — | — | US | disclosed |
| US-20110081521-A1 | HIERARCHICAL STRUCTURE AND MANUFACTURING METHOD THEREOF | KOREA INSTITUTE OF MACHINERY & MATERIALS | 2011-04-07 | — | — | US | disclosed |
| WO-1993023348-A1 | METHOD OF CERAMIC COATING | S.D. INVESTMENTS LIMITED (GB) | 1993-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12641921-B2 | Method for forming structure comprising quantum dots in surface control region, surface control substrate having structure formed to comprise quantum dots, and photoelectric element using same | EPCAM, DSG1, DSP | TSHR 1479/4885HPGD 4806/4885ALDH1A1 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.